SMT201800640T1 - Irisina per la cura e la prevenzione dell'osteoporosi - Google Patents
Irisina per la cura e la prevenzione dell'osteoporosiInfo
- Publication number
- SMT201800640T1 SMT201800640T1 SM20180640T SMT201800640T SMT201800640T1 SM T201800640 T1 SMT201800640 T1 SM T201800640T1 SM 20180640 T SM20180640 T SM 20180640T SM T201800640 T SMT201800640 T SM T201800640T SM T201800640 T1 SMT201800640 T1 SM T201800640T1
- Authority
- SM
- San Marino
- Prior art keywords
- irisin
- osteoporosis
- care
- prevention
- Prior art date
Links
- 102100026535 Fibronectin type III domain-containing protein 5 Human genes 0.000 title 1
- 101800001026 Irisin Proteins 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- LNQCUTNLHUQZLR-OZJWLQQPSA-N iridin Chemical compound OC1=C(OC)C(OC)=CC(C=2C(C3=C(O)C(OC)=C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C=C3OC=2)=O)=C1 LNQCUTNLHUQZLR-OZJWLQQPSA-N 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2015A000558A ITMI20150558A1 (it) | 2015-04-16 | 2015-04-16 | Irisina per la cura e la prevenzione dell'osteoporosi |
| EP16165324.1A EP3081228B1 (en) | 2015-04-16 | 2016-04-14 | Irisin for care and prevention of osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201800640T1 true SMT201800640T1 (it) | 2019-01-11 |
Family
ID=53490070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM20180640T SMT201800640T1 (it) | 2015-04-16 | 2016-04-14 | Irisina per la cura e la prevenzione dell'osteoporosi |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20170028018A1 (it) |
| EP (1) | EP3081228B1 (it) |
| DK (1) | DK3081228T3 (it) |
| ES (1) | ES2701675T3 (it) |
| IT (1) | ITMI20150558A1 (it) |
| PL (1) | PL3081228T3 (it) |
| PT (1) | PT3081228T (it) |
| SI (1) | SI3081228T1 (it) |
| SM (1) | SMT201800640T1 (it) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200289625A1 (en) * | 2017-10-25 | 2020-09-17 | Texas A&M University System | Uses of Irisin |
| CN111000986A (zh) * | 2019-12-10 | 2020-04-14 | 上海交通大学医学院附属第九人民医院 | 鸢尾素在制备防治骨性关节炎药物中的应用 |
| CN112773888A (zh) * | 2021-02-04 | 2021-05-11 | 上海交通大学医学院附属第九人民医院 | 鸢尾素在制备防治骨折药物中的应用 |
| WO2023048878A1 (en) * | 2021-09-24 | 2023-03-30 | The Trustees Of Indiana University | Depletion of fndc5 reduces cancer induced muscle loss/cachexia |
| CN114588176B (zh) * | 2022-02-15 | 2024-01-23 | 许静宜 | 一种研究麦冬皂苷d促进骨质疏松h型血管方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US171355A (en) * | 1875-12-21 | Improvement in driers | ||
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| GB9912350D0 (en) * | 1999-05-26 | 1999-07-28 | European Molecular Biology Lab Embl | Modified cytokine |
| FI117667B (fi) * | 2001-07-05 | 2007-01-15 | Univ Zuerich | Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä |
| EP2670847B1 (en) * | 2011-02-03 | 2016-10-05 | XOMA Technology Ltd. | Methods and materials for enhancing functional protein expression in bacteria |
| US9047069B2 (en) * | 2011-04-12 | 2015-06-02 | Texas Instruments Incorporated | Computer implemented method of electing K extreme entries from a list using separate section comparisons |
| US10093705B2 (en) * | 2011-09-13 | 2018-10-09 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for brown fat induction and activity using FNDC5 |
-
2015
- 2015-04-16 IT ITMI2015A000558A patent/ITMI20150558A1/it unknown
-
2016
- 2016-04-14 PL PL16165324T patent/PL3081228T3/pl unknown
- 2016-04-14 US US15/098,418 patent/US20170028018A1/en not_active Abandoned
- 2016-04-14 EP EP16165324.1A patent/EP3081228B1/en active Active
- 2016-04-14 SM SM20180640T patent/SMT201800640T1/it unknown
- 2016-04-14 DK DK16165324.1T patent/DK3081228T3/en active
- 2016-04-14 PT PT16165324T patent/PT3081228T/pt unknown
- 2016-04-14 ES ES16165324T patent/ES2701675T3/es active Active
- 2016-04-14 SI SI201630145T patent/SI3081228T1/sl unknown
-
2018
- 2018-01-26 US US15/880,725 patent/US10576127B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20150558A1 (it) | 2016-10-16 |
| ES2701675T3 (es) | 2019-02-25 |
| PT3081228T (pt) | 2018-12-20 |
| DK3081228T3 (en) | 2019-01-14 |
| PL3081228T3 (pl) | 2019-05-31 |
| EP3081228A1 (en) | 2016-10-19 |
| EP3081228B1 (en) | 2018-09-19 |
| SI3081228T1 (sl) | 2019-01-31 |
| US20180153960A1 (en) | 2018-06-07 |
| US10576127B2 (en) | 2020-03-03 |
| US20170028018A1 (en) | 2017-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287437A (en) | Flavociclib solid dosage forms | |
| IL253802A0 (en) | A preparation for the treatment of osteoporosis | |
| PL3283107T3 (pl) | Kompozycje zawierające kombinację ipilimumabu i nivolumabu | |
| SG11201803213XA (en) | Glycan-interacting compounds and methods of use | |
| SI3102555T1 (sl) | Sestavki spojin in njihove uporabe | |
| GB201514760D0 (en) | Compounds and method of use | |
| IL285882A (en) | Medicinal uses for l–4–chlorokynurenine | |
| IL256985A (en) | Compounds for inducing tissue formation and their uses | |
| ZA201802256B (en) | Compounds and therapeutic uses thereof | |
| IL256980B1 (en) | Compounds for inducing tissue formation and their uses | |
| ZA201703976B (en) | Dihydropyrimidine-2-one compounds and medicinal uses thereof | |
| GB201413530D0 (en) | Treatment and prevention of malaria | |
| PL3081228T3 (pl) | Iryzyna do leczenia i zapobiegania osteoporozie | |
| PL3522921T3 (pl) | Zapobieganie alergii | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| IL286670B (en) | Compounds for inducing tissue formation and their uses | |
| IL256968A (en) | Compounds for inducing tissue formation and uses thereof | |
| GB201604865D0 (en) | Patient fall prevention | |
| GB201513922D0 (en) | Treatment of hyperpigmentation |